Butterfly Network to Present at the 33rd Annual Oppenheimer Healthcare Conference

Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company, will participate in the 33rd Annual Oppenheimer Healthcare Conference from March 13-15, 2023. Executives, including Heather Getz, Darius Shahida, and Dr. John Martin, will present on March 14 at 10:40 AM ET. A live webcast will be accessible on the Butterfly investor website.

Founded in 2011, Butterfly is focused on improving global health equity through its innovative Ultrasound-on-Chip™ technology.

BURLINGTON, Mass.--(BUSINESS WIRE)-- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 33rd Annual Oppenheimer Healthcare Conference taking place virtually on March 13-15, 2023. Heather Getz, Executive Vice President & Chief Financial Officer, Darius Shahida, Chief Strategy Officer & Chief Business Development Officer, and Dr. John Martin, Chief Medical Officer will present on March 14, 2023 at 10:40am Eastern Time.

A live webcast of the presentation will be available in the Events & Presentations section of the Butterfly Network investor website.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly created the world's first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased today by trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, North America and South America; to learn more about available countries, visit: butterflynetwork.com/choose-your-country. Butterfly iQ+ is a prescription device intended for trained healthcare professionals only.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005730/en/

Investors

Heather Getz

hgetz@butterflynetinc.com

Media

Liz Learned

media@butterflynetwork.com

Source: Butterfly Network, Inc.

FAQ

When is Butterfly Network participating in the Oppenheimer Healthcare Conference?

Butterfly Network will participate in the Oppenheimer Healthcare Conference from March 13-15, 2023.

Who will present for Butterfly Network at the conference?

Heather Getz, Darius Shahida, and Dr. John Martin will present for Butterfly Network.

What time is Butterfly Network's presentation at the Oppenheimer Healthcare Conference?

Butterfly Network's presentation is scheduled for March 14, 2023, at 10:40 AM Eastern Time.

Where can I watch the Butterfly Network conference presentation?

The presentation can be watched live on the Butterfly Network investor website.

What technology does Butterfly Network use for its ultrasound devices?

Butterfly Network uses its proprietary Ultrasound-on-Chip™ technology in its ultrasound devices.